CDLX · XBRL financial data

Cardlytics financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (CDLX's year ends in late December)

In millions of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26†Jun 30, 2026
Revenue	79	89*	68	70	67	74*	62	63	52	56*	34	37
Revenue from contracts with customers	73	83*	62	64	61	68*	56	58	47	51*	34	37
Research and development	12	13*	13	13	13	10*	12	11	9	8*	6	6
General and administrative	16	14*	14	16	12	14*	14	13	11	10*	8	8
Operating income (loss)	(21)	(103)*	(23)	(16)	(149)	(8)*	(14)	(13)	(69)	(6)*	(8)	(5)
Interest income	—	year only	1	1	1	1*	1	0	1	1*	0	0
Interest expense	1	1*	2	2	2	2*	2	2	3	(18)*	3	3
Other income (expense)	(2)	3*	(1)	0	5	(6)*	3	5	(2)	(0)*	(2)	0
Income tax expense (benefit)	0	0*	—	—	—	year only	0	0	—	year only	0	0
Net income (loss)	(24)	(101)*	(24)	(4)	(145)	(16)*	(13)	(9)	(73)	(8)*	(4)	(15)
Earnings per share, basic USD per share	(0.63)	—	(0.56)	(0.09)	(2.90)	(0.31)*	(0.26)	(0.18)	(1.36)	(0.15)*	—	—
Earnings per share, diluted USD per share	(0.63)	—	(0.56)	(0.09)	(2.90)	(0.31)*	(0.26)	(0.18)	(1.36)	(0.15)*	—	—
Weighted average shares, basic millions of shares	38	39*	43	49	50	51*	52	53	53	54*	55	6
Weighted average shares, diluted millions of shares	38	36*	43	49	50	51*	52	53	53	54*	55	6

† Share count changed about 1/10 in the period ending 2026-06-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Fiscal quarters (CDLX's year ends in late December)

In millions of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26†Jun 30, 2026
Cash and cash equivalents	90	92	98	71	67	66	52	47	44	49	36	28
Marketable securities	—	—	—	—	—	—	—	—	—	0	24	—
Accounts receivable	103	121	105	103	106	103	96	93	85	83	63	68
Prepaid and other current assets	7	6	9	7	7	5	5	7	5	3	3	3
Total current assets	206	224	218	185	183	178	157	150	141	137	129	101
Property and equipment, net	3	3	3	3	3	3	2	2	2	2	2	2
Right-of-use asset	5	7	8	7	7	6	5	5	5	5	4	4
Goodwill	353	277	277	277	159	159	159	159	110	110	110	110
Total assets	635	574	569	534	399	393	369	361	293	286	264	235
Accounts payable	3	4	4	5	4	4	4	2	4	3	3	1
Accrued liabilities	10	10	4	7	8	7	8	6	7	8	10	12
Total current liabilities	179	171	103	105	156	149	132	129	124	78	59	62
Lease liability, non-current	3	6	8	7	6	6	5	5	5	5	4	4
Total liabilities	410	439	370	324	330	323	305	302	298	292	268	251
Accumulated deficit	(1,010)	(1,111)	(1,136)	(1,140)	(1,285)	(1,301)	(1,314)	(1,323)	(1,396)	(1,404)	(1,409)	(1,423)
Total stockholders' equity	225	135	199	210	70	70	64	59	(5)	(7)	(4)	(16)
Total liabilities and equity	635	574	569	534	399	393	369	361	293	286	264	235
Common shares outstanding (cover page) millions of shares	39	44	49	50	51	52	53	53	54	55	58	6

† Share count changed about 1/10 in the period ending 2026-06-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Fiscal quarters (CDLX's year ends in late December)

In millions of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26†Jun 30, 2026
Net income (loss)	(24)	(101)*	(24)	(4)	(145)	(16)*	(13)	(9)	(73)	(8)*	(4)	(15)
Stock-based compensation	10*	11*	11	13*	8*	9*	9	8*	6*	6*	5	2*
Depreciation and amortization	6*	7*	6	7*	7*	6*	6	6*	6*	6*	4	4*
Net cash from operating activities	1*	3*	(18)	4*	1*	3*	(7)	1*	2*	13*	(6)	(9)*
Purchases of property and equipment	0*	0*	1	0*	1*	0*	0	0*	0*	0*	0	0*
Net cash from investing activities	(3)*	(1)*	(5)	(5)*	(5)*	(4)*	(4)	(5)*	(4)*	(2)*	(2)	21*
Proceeds from issuing common stock	0*	0*	49	0*	0*	0*	0	0*	0*	0*	—	—
Share repurchases	0*	0*	—	—	0*	(0)*	—	—	0*	—	—	—
Repayments of long-term debt	0*	0*	0	—	—	year only	—	—	—	year only	—	—
Net cash from financing activities	0*	0*	28	(26)*	(0)*	(0)*	(3)	(2)*	(0)*	(6)*	(5)	(20)*
Net change in cash	(2)*	2*	6	(27)*	(4)*	(1)*	(14)	(5)*	(3)*	5*	(13)	(8)*

† Share count changed about 1/10 in the period ending 2026-06-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

SIC 7370 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 7370 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Runway	Quarter
Cardlytics	28	37	(8.6)*	5.9M	3.3 quarters	Q2 FY26 10-QJun 30, 2026
CareCloud	13	32	7.1*	42.5M	—	Q2 FY26 10-QJun 30, 2026
Liveperson	97	52	1.2*	12.3M	—	Q2 FY26 10-QJun 30, 2026
WM Technology	60	42	8.2*	not reported	—	Q2 FY26 10-QJun 30, 2026
Innovative Solutions & Support	11	not reported	5.1*	17.9M	—	Q3 FY26 10-QJun 30, 2026
Firy	164	31	(18)*	not reported	9.2 quarters	Q2 FY26 10-QJun 30, 2026
VPR Brands	2.1	0.7	(0.5)*	91.7M	4.0 quarters	Q2 FY26 10-QJun 30, 2026
Synchronoss Technologies	35	42	39*	11.5M	—	Q3 FY25 10-QSep 30, 2025
Marchex	8.2	11	(0.6)*	not reported	12.6 quarters	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.